Subscribe To
Immuneering presents preclinical data with lead program imm-1-104 supporting universal-ras activity
Broad response demonstrated through deep cyclic inhibition of MAPK pathway, independent of specific RAS mutation Phase 1/2a clinical trial with IMM-1-...
March 5, 2023, 11:30 pm
Nerdy stock surged 44% last week. here's why.
Nerdy's learning memberships are proving popular with students. CEO Chuck Cohn sees a path to adjusted ...
March 5, 2023, 10:47 pm
Why bitcoin looks poised to pop higher
Each day that Bitcoin’s price doesn’t pull back substantially, it increases the chances we’re on the cusp of seeing a major bullish leg higher. ...
March 5, 2023, 6:29 pm
Amarin announces new reduce-it® data at acc.23/wcc showing benefit of vascepa®/vazkepa® (icosapent ethyl) in high-risk patients with a recent acute coronary syndrome event
–Post-Hoc Analysis Shows IPE Significantly Reduced Risk of First, Total Ischemic Events by 37% and 36% Respectively in Patients with Recent ACS With...
March 5, 2023, 3:21 pm
Stop human traffickers, pope francis says after italy’s migrant shipwreck
VATICAN CITY (Reuters) – pope Francis on Sunday called on authorities to stop human traffickers opera...
March 5, 2023, 12:21 pm
Mgv: a cost-efficient vanguard value etf for diversification
With the advent of the 2022 bear market, and the end of near 0% interest rates, "value" investing has become more ...
March 5, 2023, 11:39 am
2 volatile etfs are gaining popularity. realize the risks.
These volatile ETFs can make a lot of money in the right market, but they can lose a ton in the wrong market....
March 5, 2023, 11:23 am
A bull market is coming: 1 magnificent growth stock down 87% to buy now and hold forever
Roku's growth has decelerated due to inflationary headwinds, and the stock has fallen 87% from its high. Roku's ...
March 5, 2023, 6:55 am
Odoge solidifies its place in bitcoin and memecoin history with acquisition of first-ever doge ordinal for 10btc
Ordinal Doge combines conventional and smart contracts on Ethereum to unlock the power of Bitcoin and create a distinctive feature coin that is gainin...
March 4, 2023, 11:00 pm
With only 3% of total traded volume, is social trading "dead?”
The Social Trading concept was introduced for the first time over a decade ago, in 2008. It quickly gained ...
March 4, 2023, 8:02 pm
Mutual funds weekly: these money and investing tips can unlock valuable stock-market secrets
Money and investing stories popular with MarketWatch readers over the past week. Read Full Story The po...
March 4, 2023, 5:41 pm
Landmark clear outcomes study demonstrates nexletol® (bempedoic acid) tablet is the only ldl-c lowering therapy since statins to reduce hard ischemic events in a broad population of both primary preve
Results Demonstrate Significant Reductions in LDL-C, hsCRP and Cardiovascular Risk in Patients Who Are Unable to Maximize or Tolerate a Statin – NEX...
March 4, 2023, 3:30 pm
Landmark clear outcomes study demonstrates nexletol® (bempedoic acid) tablet is the only ldl-c lowering therapy since statins to reduce hard ischemic events in a broad population of both primary preve
Results Demonstrate Significant Reductions in LDL-C, hsCRP and Cardiovascular Risk in Patients Who Are Unable to Maximize or Tolerate a Statin – NEX...
March 4, 2023, 3:30 pm
Landmark clear outcomes study demonstrates nexletol® (bempedoic acid) tablet is the only ldl-c lowering therapy since statins to reduce hard ischemic events in a broad population of both primary preve
Results Demonstrate Significant Reductions in LDL-C, hsCRP and Cardiovascular Risk in Patients Who Are Unable to Maximize or Tolerate a Statin – NEX...
March 4, 2023, 3:30 pm
Landmark clear outcomes study demonstrates nexletol® (bempedoic acid) tablet is the only ldl-c lowering therapy since statins to reduce hard ischemic events in a broad population of both primary preve
Results Demonstrate Significant Reductions in LDL-C, hsCRP and Cardiovascular Risk in Patients Who Are Unable to Maximize or Tolerate a Statin – NEX...
March 4, 2023, 3:30 pm
Landmark clear outcomes study demonstrates nexletol® (bempedoic acid) tablet is the only ldl-c lowering therapy since statins to reduce hard ischemic events in a broad population of both primary preve
Results Demonstrate Significant Reductions in LDL-C, hsCRP and Cardiovascular Risk in Patients Who Are Unable to Maximize or Tolerate a Statin – NEX...
March 4, 2023, 3:30 pm
Landmark clear outcomes study demonstrates nexletol® (bempedoic acid) tablet is the only ldl-c lowering therapy since statins to reduce hard ischemic events in a broad population of both primary preve
Results Demonstrate Significant Reductions in LDL-C, hsCRP and Cardiovascular Risk in Patients Who Are Unable to Maximize or Tolerate a Statin – NEX...
March 4, 2023, 3:30 pm
$30 million worth of funko pop figurines are headed to the dump, as the company looks to purge excess inventory
The move comes after Funko pop inventory ballooned nearly 50% in the last year, with unsold toys clutte...
March 4, 2023, 10:51 am
Ai stock headlines 5 leaders flashing buy signals as market rally gains steam
Arista Networks, which keeps popping up on lists of top AI stocks, leads this weekend's watch list of 5...
March 4, 2023, 8:59 am
Think tesla is losing popularity? think again
If you thought Tesla's brand was losing some popularity after multiple price adjustments -- among other...
March 4, 2023, 7:15 am
